Navigation Links
Steroid-Free Liver Transplants

A new study out of Belgium suggests children undergoing liver transplants may fare better if they don't receive steroids. //

Ever since organ transplants began, steroids have played a major role in helping recipients fend off rejection of their new organ. However, the treatment is not without side effects, especially in children. Steroids have been linked to infections, high blood pressure, elevated blood cholesterol, and impaired growth in young patients.

Researchers in this study tested the use of a newer anti-rejection drug in a group of 20 children needing liver transplants to see if the new drug might solve some of these problems. The patients received a combination therapy in which the drug basiliximab replaced steroids in an otherwise standard treatment.

The children were all followed for at least a year. Investigators compared outcomes for the group with those from a similar group of 20 children who had received liver transplants in the past and had been given steroid treatment.

The study found children on the newer combination of medications had a 25 percent graft rejection rate after one year vs. 50 percent among those who had received steroid therapy following their transplant. Children on the new treatment also had a reduced need for high blood pressure medications and appeared to begin catching up on growth soon after their transplant. Cholesterol levels at the one-year follow up were about the same in the children who received the new treatment as those seen among kids who received the standard treatment with steroids.

Author Raymond Reding notes, "Our results suggest no harmful effect of steroid avoidance for graft acceptance, but this finding will need to be confirmed after extended follow-up."


'"/>




Page: 1

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. Liver donors can thrive after transplant
3. Heavy Drinking Raises Risk of Liver Cancer
4. Arthritis Drug May Cause Liver Damage
5. Liver transplant oversight urged
6. Liver key to extending life
7. Liver cancers which spread are linked to a particular gene
8. Liver diseases: The enemy with an accomplice
9. Troubled Childhood found to affect your Liver
10. New Liver Tumor Treatment
11. Transplants Help Liver Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... , ... Mercy College is expanding its Graduate Business Programs to the Bronx ... to high demand: Master of Business Administration (MBA), Master of Organizational Leadership (MSOL) and ... School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe that people ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for ... and mood optimization products to the store is just one more way Shamangelic ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... Fla. (PRWEB) , ... April 29, 2016 , ... ... Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have better ... is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
Breaking Medicine Technology: